Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|November 6, 2010
Proteinuria in diabetes: bystander or pathway to cardiorenal disease?Janaka Karalliedde, Giancarlo VibertiNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2015
Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsLuigi Gnudi, Janaka KarallieddeDiabetes, Obesity & Metabolism|July 24, 2024
Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trialKhuram Chaudhry, Janaka KarallieddeNature Reviews. Nephrology|January 21, 2015
Diabetes. Excess mortality in well-controlled T1DM without renal diseaseJanaka Karalliedde, Giancarlo VibertiFuture Cardiology|October 7, 2009
Future strategies to prevent renal microvascular disease complications in diabetesJanaka Karalliedde, Luigi GnudiIntegrated Blood Pressure Control|September 28, 2011
Critical appraisal of the differential effects of antihypertensive agents on arterial stiffnessFrancesca Kum, Janaka KarallieddeInternational Journal of Hypertension|November 29, 2011
The putative role of the antiageing protein klotho in cardiovascular and renal diseaseGiuseppe Maltese, Janaka KarallieddeNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 2015
Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney diseaseJanaka Karalliedde, Luigi GnudiAmerican Journal of Hypertension|October 16, 2004
Microalbuminuria and cardiovascular riskJanaka Karalliedde, Giancarlo VibertiDrug Safety|August 29, 2007
Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategiesJanaka Karalliedde, Robin E BuckinghamPageof 10